← Leaderboards
Kenneth L Pitter
Weill Medical Coll Of Cornell Univ
$2,110,014
Attributed
$2,110,014
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $393.8K · FY2011–25$500K$375K$250K$125K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,110,014 · 2
By mechanism
DP5$1,968,750 · 1
F31$141,264 · 1
Top collaborators
No co-investigators on record.
Most similar at Weill Medical Coll Of Cornell Univ
Same institution · by research overlap
- Dingcheng Gao$4,134,819
- Steven Monroe Lipkin$27,661,021
- Jorge Moscat$21,067,408
- Stefan Ross Torborg$231,114
- Lukas Edward Dow$10,323,278
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsMolecularPathway InteractionsTreatment StrategyBiologicalPhenotypeGenetically Engineered MouseOperative Surgical ProceduresRadiationResistanceTumorCharacteristicsCellsPropertyChemotherapyGeneticStemCancer HeterogeneityCancer CellAnimalsCancer BiologyAnimal ExperimentationAcyltransferaseColorectal Adenocarcinoma
Grant awards (8)
Cellular phenotypic heterogeneity and resistance to radiotherapy in pancreatic adenocarcinoma$393,750
DP5 · FY2025 · OD · contact PI
Cellular phenotypic heterogeneity and resistance to radiotherapy in pancreatic adenocarcinoma$393,750
DP5 · FY2024 · OD · contact PI
Cellular phenotypic heterogeneity and resistance to radiotherapy in pancreatic adenocarcinoma$393,750
DP5 · FY2023 · OD · contact PI
Cellular phenotypic heterogeneity and resistance to radiotherapy in pancreatic adenocarcinoma$393,750
DP5 · FY2022 · OD · contact PI
Cellular phenotypic heterogeneity and resistance to radiotherapy in pancreatic adenocarcinoma$393,750
DP5 · FY2021 · OD · contact PI
Characterizing the functional stem-like properties of primary and recurrent gliom$47,232
F31 · FY2013 · NS · contact PI
Characterizing the functional stem-like properties of primary and recurrent gliom$47,232
F31 · FY2012 · NS · contact PI
Characterizing the functional stem-like properties of primary and recurrent gliom$46,800
F31 · FY2011 · NS · contact PI